The Patent Finder

Apoxis S. A.

Also on record
Records under this name other than patents Apoxis S. A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Apoxis S. A.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,736,657Fusion constructs containing active sections on TNF ligands
Formerly held
Term ended
Term ended Mar 28, 2024 · USPTO record
Term endedTerm ended Mar 28, 2024USPTO record
US 7,385,032Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins
Formerly held
Term ended
Term ended Aug 9, 2023 · USPTO record
Term endedTerm ended Aug 9, 2023USPTO record
US 7,691,804Baff Receptor (BCMA), an Immunoregulatory Agent
Formerly held
Term ended
Term ended May 15, 2023 · Medium confidence
Term endedTerm ended May 15, 2023Medium confidence
US 8,501,177Treatment of ectodermal dysplasia with EDA1 fusion proteins
Term ended
Term ended Mar 20, 2023 · USPTO record
Term endedTerm ended Mar 20, 2023USPTO record
US 7,083,785Methods of Treatment by Administering an Anti-Bcma Antibody
Formerly held
Term ended
Term ended Jan 4, 2022 · Medium confidence
Term endedTerm ended Jan 4, 2022Medium confidence
US 8,828,669Methods of Screening for a Compound That Inhibits the Interaction Between Baff and Bcma
Formerly held
Term ended
Term ended Aug 16, 2020 · Medium confidence
Term endedTerm ended Aug 16, 2020Medium confidence
US 9,650,430Methods of Treating Autoimmune Diseases Using a B-Cell Maturation Antigen (BCMA)
Formerly held
Term ended
Ended no later than Aug 16, 2020 · Low confidence
Term endedEnded no later than Aug 16, 2020Low confidence
US 10,494,416Methods of Modulating Immune Responses Using Bcma Polypeptide
Formerly held
Term ended
Term ended Aug 16, 2020 · Medium confidence
Term endedTerm ended Aug 16, 2020Medium confidence
US 7,276,241Methods of Treating a Tumor That Expresses April by Administering Bcma
Formerly held
Lapsed on the fee record
Ended Oct 2, 2019 · Medium confidence
Lapsed on the fee recordEnded Oct 2, 2019Medium confidence
US 7,223,852Nucleic Acids Encoding Train-R: a Cysteine Rich Member of the Tnf-Receptor Family
Formerly held
Lapsed on the fee record
Ended May 29, 2019 · Medium confidence
Lapsed on the fee recordEnded May 29, 2019Medium confidence
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited